113 related articles for article (PubMed ID: 8299234)
1. Functional domains on HLA-DR molecules: implications for the linkage of HLA-DR genes to different autoimmune diseases.
Weyand CM; Goronzy JJ
Clin Immunol Immunopathol; 1994 Feb; 70(2):91-8. PubMed ID: 8299234
[No Abstract] [Full Text] [Related]
2. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.
Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
J Clin Invest; 1992 Dec; 90(6):2355-61. PubMed ID: 1469092
[TBL] [Abstract][Full Text] [Related]
3. Molecular mimicry with MHC-derived peptides: does this underlie MHC association with autoimmune disease?
Baum H
Biochem Soc Trans; 1997 May; 25(2):636-42. PubMed ID: 9191171
[No Abstract] [Full Text] [Related]
4. Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis.
Diab BY; Lambert NC; L'Faqihi FE; Loubet-Lescoulié P; de Préval C; Coppin H
Immunogenetics; 1999 Jan; 49(1):36-44. PubMed ID: 9811967
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.
Weyand CM; Hunder NN; Hicok KC; Hunder GG; Goronzy JJ
Arthritis Rheum; 1994 Apr; 37(4):514-20. PubMed ID: 8147928
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the HLA-DR association of rheumatoid arthritis.
Sinigaglia F; Nagy ZA
Curr Dir Autoimmun; 2001; 3():36-50. PubMed ID: 11791470
[No Abstract] [Full Text] [Related]
7. Linkage between rheumatoid arthritis susceptibility and the presence of HLA-DR4 and DR beta allelic third hypervariable region sequences in southern Chinese persons.
Seglias J; Li EK; Cohen MG; Wong RW; Potter PK; So AK
Arthritis Rheum; 1992 Feb; 35(2):163-7. PubMed ID: 1346498
[TBL] [Abstract][Full Text] [Related]
8. HLA-D region genes and susceptibility to rheumatoid arthritis.
Singal DP; Ye M; Buchanan WW; Qiu X
Transplant Proc; 1997; 29(1-2):1126. PubMed ID: 9123229
[No Abstract] [Full Text] [Related]
9. Could HLA-DRB1 be the protective locus in rheumatoid arthritis?
Zanelli E; Gonzalez-Gay MA; David CS
Immunol Today; 1995 Jun; 16(6):274-8. PubMed ID: 7544977
[TBL] [Abstract][Full Text] [Related]
10. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
[TBL] [Abstract][Full Text] [Related]
11. A genetic basis for autoimmune manifestations in the abdominal aortic aneurysm resides in the MHC class II locus DR-beta-1.
Tilson MD; Ozsvath KJ; Hirose H; Xia S
Ann N Y Acad Sci; 1996 Nov; 800():208-15. PubMed ID: 8958995
[No Abstract] [Full Text] [Related]
12. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.
Patil NS; Pashine A; Belmares MP; Liu W; Kaneshiro B; Rabinowitz J; McConnell H; Mellins ED
J Immunol; 2001 Dec; 167(12):7157-68. PubMed ID: 11739539
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis.
Wang Q; Drouin EE; Yao C; Zhang J; Huang Y; Leon DR; Steere AC; Costello CE
J Proteome Res; 2017 Jan; 16(1):122-136. PubMed ID: 27726376
[TBL] [Abstract][Full Text] [Related]
14. Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders.
Weyand CM; Jendro M; Goronzy JJ
Autoimmunity; 1991; 8(4):281-7. PubMed ID: 1932512
[TBL] [Abstract][Full Text] [Related]
15. New molecular approaches to tissue typing.
Wade JA
Transplant Proc; 1996 Aug; 28(4):2022-3. PubMed ID: 8769142
[No Abstract] [Full Text] [Related]
16. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
Auger I; Sebbag M; Vincent C; Balandraud N; Guis S; Nogueira L; Svensson B; Cantagrel A; Serre G; Roudier J
Arthritis Rheum; 2005 Nov; 52(11):3424-32. PubMed ID: 16255019
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica.
Guerne PA; Salvi M; Seitz M; Bruhlmann P; Rivier G; Frey D; Mermillod B; Vischer TL; Tiercy JM
J Rheumatol; 1997 Apr; 24(4):671-6. PubMed ID: 9101500
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of HLA-DR beta and DQ beta polymorphism in Chinese with rheumatoid arthritis.
Molkentin J; Gregersen PK; Lin X; Zhu N; Wang Y; Wang Y; Chen S; Chen S; Baxter-Lowe LA; Silver J
Ann Rheum Dis; 1993 Aug; 52(8):610-2. PubMed ID: 8215626
[TBL] [Abstract][Full Text] [Related]
19. Correlation between HLA-DR sequence polymorphisms and rheumatoid factor production.
Weyand CM; Goronzy JJ
Ann N Y Acad Sci; 1997 Apr; 815():353-6. PubMed ID: 9186677
[No Abstract] [Full Text] [Related]
20. The down-regulation of HLA-DM gene expression in rheumatoid arthritis is not related to their promoter polymorphism.
Louis-Plence P; Kerlan-Candon S; Morel J; Combe B; Clot J; Pinet V; Eliaou JF
J Immunol; 2000 Nov; 165(9):4861-9. PubMed ID: 11046010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
